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Abstract
Antimicrobial peptides (AMP), part of the innate immune system, are well studied for their
ability to kill pathogenic microorganisms. However, many also possess important immuno-
modulatory effects, and this area has potential for the development of novel therapies to
supplement traditional methods such as the use of antibiotics. Here, we characterise the
microbicidal and immunomodulatory potential of the proline-rich bovine AMP, Bactenecin 5
(Bac5). We demonstrate broad antimicrobial activity, including against some mycobacterial
species, which are important pathogens of fish, cattle and humans. Bac5 is able to activate
macrophage-like THP-1 cells and can synergistically trigger the upregulation of tnf-α when
co-stimulated with M. marinum. Furthermore, Bac5 sensitises A549 epithelial cells to stimu-
lation with TNF-α. For the first time, we characterise the activity of Bac5 in vivo, and show it
to be a potent chemokine for macrophages in the zebrafish (Danio rerio) embryo model of
infection. Bac5 also supports the early recruitment of neutrophils in the presence of M. mari-
num. In the absence of host adaptive immunity, exogenous injected Bac5 is able to slow,
although not prevent, infection of zebrafish with M. marinum.
Introduction
The rising incidence of antimicrobial resistance and decline in major commercial investment
into new antimicrobial development is driving the innovative use of alternative compounds
and novel strategies to combat infection. Antimicrobial peptides (AMP) are a conserved but
diverse group of innate immune effectors that have been well studied for their ability to kill
bacteria, fungi and viruses (reviewed by Radek et al [1]). They are usually small, typically
below fifty amino-acids in length, tend to be cationic and hydrophobic, and can have an array
of secondary structures and modifications. The sheer diversity of possible sequence variations
lends them to the rational design of novel AMP derivatives, which is a promising avenue of
research [2–6]. The study of naturally occurring AMP can be used to identify those that carry
properties that may be desirable in new therapeutics, as well as elucidating their natural role
during infection.
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While some AMP act through direct lysis of the bacterial cell membrane, others target
intracellular sites, including heat-shock proteins and ribosomal subunits (reviewed by Mishra
et al [7]). Furthermore, some have been reported to contribute to wound healing [8] and
angiogenesis [9]. The only human AMP belonging to the cathelicidin-family is LL37; which, in
addition to human beta defensin (HBD)3, has been described as chemotactic for neutrophils,
T-cells [10], macrophages [11], immature dendritic cells [10] and mast cells [11]. It is these
non-bactericidal properties of AMP that are garnering interest for their potential application
as immunoregulators to treat disease. An attractive aspect of this approach is that since the
AMP does not depend on direct microbicidal activity, rather supporting the host immune
response to eradicate infection, it may confer less selective pressure to evolve resistance.
Immunomodulatory AMPs have already entered clinical trials for the treatment of acne, rosa-
cea and malaria [12].
Bactenecins (Bac) comprise a family of cyclic peptides released by activated bovine neutro-
phils upon degranulation [13]. Bac5, also known as bovine cathelicidin-2, is unusual in that it
is particularly arginine-proline rich, a feature normally associated with insect and crustacean
AMPs, and otherwise so far only identified in ruminants.
Since it lacks any cysteine residues, Bac5 cannot form disulphide bridges and exists in a lin-
ear conformation [14]. Linearised forms of other bactenecins are reportedly less active against
Gram-negative species, but more active against Gram-positive species, compared with their
cyclised form [15]. Bac5 is reportedly non-lytic [16] and can be internalised by some bacteria
via a transport-mediated mechanism to reach intracellular targets [17]. However, there are sev-
eral reports that Bac5 can also fuse with and alter the morphology of bacterial membranes, and
this correlates with microbicidal activity [18, 19]. Bac5 demonstrates species-restricted bacteri-
cidal activity, particularly against Gram-negative bacteria including Escherichia coli, Burkhol-
deria pseudomallei [20] and Klebsiella sp. [21], but retains some limited activity against certain
Gram-positive species: it can kill Staphylococcus epidermidis, for example, but not S. aureus.
Meanwhile it has also been shown to be able to kill Candida albicans [22]. To our knowledge,
the activity of bovine Bac5 against mycobacteria has not been investigated.
Although synthesised during myelopoiesis [23], Bac5 is also strongly upregulated upon
intramammary challenge with Streptococcus uberis [24] and E. coli, although in goats it appears
to be constitutively expressed in healthy somatic milk cells [25]. Interestingly, despite its tran-
scriptional upregulation in this tissue, the peptide itself has dramatically reduced minimum
inhibitory concentration (MIC) in bovine serum and milk [26]. Still, the pro-form of the pep-
tide may retain chemotactic properties that are still of benefit to the host, similar to the related
peptide, Bac7 [27]. Proteolytic cleavage of pro-Bac5 to the mature Bac5 form is thought to
occur rapidly, within five minutes [13, 28], while mRNA expression of Bac5 appears to peak at
around 20 hours post-stimulation of neutrophils with E. coli as stores of the pro-peptide are
replenished [29]. These findings point to an important sentinel role for Bac5 in peripheral tis-
sue in preventing infection. However, the non-bactericidal effects of Bac5, particularly with
regards to important host cell types involved in innate immunity, as well as in the context of
mycobacterial infection have not been well studied.
Proline-rich peptides, such as those isolated from bovine colostrum, have been shown to
counteract the Th2-dominated allergic inflammatory response and promote a Th1-associated
outcome, for example by the induction of IFN-γ and TNF-α in human leukocytes and whole
blood cultures [30]. It is believed that this type of immune response may be important in pro-
tection against progressive mycobacterial infection [31]. Immunomodulation by other bovine
AMP has been reported, with indolicidin shown to induce CXCL8; and Bac7, structurally simi-
lar to Bac5, potentially able induce DNA synthesis and proliferation of fibroblasts [28]. Some
promising research has demonstrated that some AMP can neutralise lipopolysaccharide and
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reduce TLR4-mediated inflammation, offering a potential new treatment for sepsis through
detoxification [32–38]. Certain modern synthetic peptides derived from the native Bac2
sequence are also able to upregulate expression of potent chemokines such as MCP-1 [39].
In this study, we sought to investigate the bactericidal and immunomodulatory properties
of Bac5 in vitro and in vivo, in the presence and absence of mycobacterial infection. We use the
zebrafish (Danio rerio) embryo infection model along with its natural pathogen, M. marinum
[40, 41]. This system confers several advantages: the zebrafish embryos are transparent and
therefore amenable to fluorescence imaging of bacteria and host cell types [42]; they do not
encode proline-rich AMP, enabling the study of Bac5 in isolation; and finally, they lack a
developed adaptive immune response (reviewed by Trede et al [43]), enabling us to character-
ise the capabilities and limitations of Bac5 in a purely innate context.
Results
Bac5 Has species-selective antibacterial activity
The active portion of the Bac5 amino acid sequence was synthesised, purified and tested for
activity against different Gram-negative and Acid-Fast species of bacteria. The peptide demon-
strated significant, concentration-dependent ability to restrict metabolic activity in all bacteria
species tested (Fig 1A). Bac5 was variably microbicidal against all species, mostly correlating
well with the metabolic assay, although Y. pseudotuberculosis and M. bovis BCG both demon-
strated greater resistance to the peptide, and required higher concentration of Bac5 to signifi-
cantly reduce CFU (Fig 1B).
Bac5 modulates chemokine and cytokine transcriptional activity in
response to M. marinum and tnf-α challenge in vitro
We characterised the immunomodulatory effect of Bac5 in vitro by looking directly at its effect
on key cell types and cytokines associated with mycobacterial infection. We studied the effect
of Bac5 on matured human THP-1 macrophage-like cells, and found that synthetic Bac5 and
Fig 1. Antibacterial effect of Bac5 against gram-negative and Acid-Fast bacilli. The active fragment of Bac5 was synthesised to high purity and incubated at different
concentrations with mid-log phase bacteria of different species in a sterile solution of RPMI:Water (1:4, v:v). Metabolic activity (A) was calculated using the colorimetric
Alamar Blue assay, while bactericidal activity was recorded by colony forming unit (CFU) assay (B). All data were collected at 24 hours, except for M. bovis BCG, where
metabolic activity was recorded after 72 hours. Stars denote statistical (p< 0.01) significance from the untreated (zero) control for each species as calculated using
Student’s T-test.
https://doi.org/10.1371/journal.pone.0210508.g001
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epinecidin induced the transcription of IL-1β both in the presence and absence of live M. mari-
num in THP-1 cells (Fig 2A & 2B). Interestingly, Bac5 was the only peptide tested to signifi-
cantly upregulate tnf-α, but only in synergy with M. marinum. Epinecidin significantly
upregulated both mmp-9 and IL-1β, particularly in the presence of the bacteria. Collectively,
these results show that Bac5 is able to activate macrophage-like cells in vitro in the absence of
additional host cell types or cytokines.
We looked for the same cytokine responses in vivo using the zebrafish embryo model, fol-
lowing infection with M. marinum and treatment with a single injection of 10 ng Bac5 in the
hindbrain ventricle (HBV). Whilst M. marinum induced il-1β, mmp-9 and cxcl-c1c after 96
hours, Bac5 did not significantly affect this outcome (S1 Fig), in contrast to our in vitro find-
ings. To establish whether injection of Bac5 at later stages post-infection influenced the cyto-
kine profile, we allowed the infection to proceed to either 72 or 90 hpi before treating with
Bac5, and again found no significant difference from the untreated control (S2 Fig).
To examine whether endogenously-produced Bac5 could also modulate chemokine and
cytokine responses by host cells in vitro, we transformed the adherent human epithelial cell
line, A549 to stably express Bac5. We confirmed Bac5 expression by A549 cell lines by both
transcriptional analysis and also by phenotypic assay, confirming that, as with the synthetic
version of the peptide, A549 cells expressing Bac5 could inhibit bacterial metabolic activity.
Fig 2. Effect of Bac5 on THP-1 cell cytokine transcription during infection. Fold change of IL-1β, TNF-α and MMP-9 mRNA levels in uninfected (A) and M.
marinum-infected (B) resting THP-1 cells following incubation with 15 ng/μl AMPs for 24 h. Fold changes of mRNA levels were assessed by qRT-PCR, normalised to
18S and expressed relative to one control (no treatment) sample. Data pooled from two independent experiments is shown. Each data point represents two treatment
wells (n = 12). Error bars represent S.E.M. Kruskal-Wallis with Dunn’s post-test. ��p<0.01, �p<0.05.
https://doi.org/10.1371/journal.pone.0210508.g002
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The finding that this only occurred in culture supernatant and not lysate indicated that the
peptide was readily secreted (S3A and S3B Fig). We furthermore examined the effect of
endogenously-produced Bac5 in response to stimulation with either live mycobacteria or to
the inflammatory cytokine, TNF-α. Bac5 only weakly affected MMP-9 and CXCL8 secretion
by epithelial cells when stimulated with mycobacteria, but significantly upregulated both cyto-
kines in response to TNF-α stimulation in the absence of bacteria (S3C and S3D Fig).
Bac5 induces rapid, sustained macrophage and transient neutrophil
recruitment in vivo
Infection of the zebrafish embryo HBV with M. marinum induced the recruitment of macro-
phages to the site from 3–24 hpi (Fig 3). In the absence of bacteria, 10 ng Bac5 was also able to
Fig 3. Injection of Bac5 to the hindbrain ventricle (HBV) increases macrophage recruitment. Two days post-fertilisation Tg(mpeg-1:mCherry) zebrafish embryos
were injected into their HBV with Mock, BAC, Mock/M. marinum (Mmar) or BAC/Mmar. 10 ng Bac5 was injected for both Bac5 treatment groups and approximately
190 CFU Mmar expressing GFP for both infection groups. Z-stack images of the HBV region were acquired at 3 hours post-injection (hpi) and 24 hpi. (A-H)
Representative fluorescence overlay images of fish at 3 hpi (A-D) and 24 hpi (E-H) from a single experiment are shown. Scale bar 100 μm. (I-J) Macrophages in the HBV
region were quantified from fluorescence images of zebrafish taken at 3 hpi (I) and 24 hpi (J) using Icy Spot Detector plugin. Data pooled from three independent
experiments is shown. Sample size (n): 40, 36, 61, 53. Error bars represent S.E.M. One-way ANOVA with Bonferroni’s post-test. �p<0.05, ���p<0.001.
https://doi.org/10.1371/journal.pone.0210508.g003
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induce recruitment of macrophages, however co-injection of bacteria with peptide did not sig-
nificantly enhance macrophage recruitment above the levels induced by bacteria alone.
Beyond 24 hpi, macrophages aggregated into nascent granulomatous-like structures and were
no longer discernible as discrete cells.
In contrast to macrophages, M. marinum did not induce neutrophil recruitment until 72
hpi. Interestingly, co-injection with Bac5 enabled the recruitment of neutrophils significantly
earlier, at 6 hpi (Fig 4). Yet by 72 hpi, there was no discernible effect of Bac5 above the level of
neutrophils recruited by M. marinum alone. Similarly, delayed injections of Bac5 at later time
points (48 hpi and 96 hpi) showed that there was no significant difference in neutrophil count
compared with M. marinum alone (S4 Fig).
Co-injection of Bac5 with M. marinum slows the rate of bacterial infection
As a marker of bacterial burden, we quantified the fluorescence intensity of a reporter-strain
of M. marinum, which enabled us to measure the progression of infection in real-time for each
Fig 4. Injection of Bac5 to the HBV induces early but not sustained neutrophil recruitment. Two days post-fertilisation casper Tg(mpx:GFP) zebrafish embryos
were injected into their HBV with Mock, Bac5, Mock/M. marinum (Mmar) or Bac5/Mmar. 10 ng BAC was injected for both BAC treatment groups and
approximately 250 CFU Mmar expressing DsRed2 for both infection groups. Z-stack images of the HBV region were acquired at 6 hpi, 24 hpi and 72 hpi. (A-D)
Representative fluorescence overlay images of fish from a single experiment are shown at 6 hpi. Scale bar 100 μm. (E-H) Representative fluorescence images of fish
from the same single experiment are shown at 72 hpi. Images of the bacterial fluorescence channel are shown only for infected zebrafish groups, separated by white
dashed line from the neutrophil channel images. Scale bar 100 μm. (I-K) Neutrophils in the HBV region were quantified from fluorescence images of zebrafish
embryos using Icy Spot Detector plugin. From L to R: 6 hpi, 24 hpi and 72 hpi. Data was also analysed using Icy FPC protocol with the same outcome (S5 Fig).
Sample size (n) = 39, 37, 38, 43. Data pooled from three independent experiments is shown. Error bars represent S.E.M. One-way ANOVA with Bonferroni’s post-
test. �p<0.05, ��p<0.01, ���p<0.001.
https://doi.org/10.1371/journal.pone.0210508.g004
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embryo. Whilst we observed a significantly reduced bacterial burden in the Bac5-treated con-
dition, this was only apparent at 72 hpi, and the overall trend was still increased bacterial bur-
den over time, suggesting the peptide treatment may slow, but not prevent colonisation by M.
marinum (Fig 5).
To investigate whether Bac5 could affect bacterial burden of an established infection, we
allowed infection to proceed unchallenged until administering Bac5 at 48 hpi, with a repeat
treatment at 96 hpi. However, in this model there was also no protective benefit of the AMP
treatment, either in reducing bacterial burden or in embryo survival (S5 Fig).
Discussion
Mycobacteria are able to redirect the host immune response from one that is able to clear the
infection (Th1) towards one that supports persistence (Th2) that can last for many years [44].
Dysregulation of the immune response can also result in excessive and damaging immunopa-
thology [31, 45]; AMP may offer a solution for restoring an effective host response. In the pres-
ent work, we sought to characterise the immunomodulatory properties of the proline-rich
bovine AMP, Bac5. In particular, we wanted to examine its in vivo potential using the embry-
onic zebrafish model in the context of early infection with virulent M. marinum, a close rela-
tive of M. tuberculosis.
In vitro activity of Bac5
Bac5 was found to broadly restrict metabolic activity across a number of different bacterial spe-
cies. However, its killing activity was more species-selective, with Y. pseudotuberculosis and M.
bovis BCG demonstrating greater resistance to the peptide than other species, although they
were still sensitive to higher concentrations. These findings fit with observations that Bac5 can
fuse with bacterial membranes [18] and with reports that Bac2 is active against Gram-negative
bacilli [15]. A suggested target for Bac5 is through the ABC transporter, SbmA, which facili-
tates uptake of the peptide. While SbmA is conserved amongst Gram-negative bacteria, it is
not among Gram-positive species (24). We are the first to report Bac5 microbicidal activity
against mycobacterial species; interestingly, a BLAST comparison revealed that Mycobacterium
spp. possess an orthologous ABC transporter, to SbmA, but with only 24% identity. The mech-
anism of uptake and killing by Bac5 therefore remains to be proven.
Fig 5. Exogenous injected Bac5 slows rate of infection with m. marinum in zebrafish embryos. Two days post-fertilisation casper Tg(mpx:GFP) zebrafish embryos
were injected into their HBV with 10 ng Bac5 or mock control along with approximately 250 CFU Mmar expressing DsRed2 for both infection groups. Zebrafish
embryos were live-imaged using a fluorescence stereomicroscope and z-stack images of the HBV region acquired at 6 hpi, 24 hpi and 72 hpi. Bacterial burden in the
HBV region of M. marinum–infected zebrafish embryos was quantified from fluorescence images using Icy FPC protocol. Sample size (n): 38, 43. Data pooled from
three independent experiments is shown. Error bars represent S.E.M. Mann-Whitney test. �p<0.05.
https://doi.org/10.1371/journal.pone.0210508.g005
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We found that Bac5 was able to significantly upregulate the transcription of both IL-1β and
TNF-α in mature THP-1 cells, indicating that it can activate macrophage-like cells in vitro.
The induction of IL-1β by Bac5 was of interest since it is reported to be an important mediator
of host resistance to MTB infection [46–48]. IL-1 gene knockout studies have shown its impor-
tance in reducing bacterial burden and improving survival in mice [49–51], while mice that
are deficient in IL-1 receptor demonstrate greater necrosis in response to MTB infection [50,
52].
Since we detected concomitant IL-1β and TNF-α transcriptional activity, we could not
determine whether Bac5 directly upregulated TNF-α since it has been reported that IL-1β can
itself induce TNF-α [53–55]. Interestingly, our findings contrast with the reported inability of
Bac5 to upregulate TNF-α in bovine epithelial cells [26], suggesting this may be a cell-type spe-
cific effect. The ability of Bac5 to activate THP-1 cells optimally required co-stimulation with
M. marinum. This is analogous to the classical activation pathway of macrophages which
requires two signals: a pathogen-associated molecular pattern (PAMP) and a pro-inflamma-
tory cytokine such as IFN-γ [56, 57]. It contrasts with human LL37, which could kill M. mari-
num, but not induce TNF-α in our hands.
While TNF-α is important in the host response to mycobacterial infection, it can also pro-
mote tissue damage if unregulated [58–60]. For this reason, we were particularly interested to
examine co-induction of MMP-9. MMP-9 is a metalloprotease that has been associated with
macrophage recruitment and wound healing, and the formation of well-defined and stable
granuloma in both murine and zebrafish models of mycobacterial infection [61, 62]. We
found that epinecidin induced MMP-9 in synergy with M. marinum in THP-1 cells. With
Bac5, the response was variable, with only about half the replicates showing strong induction
of MMP-9 in response to Bac5 treatment. In A549 cells endogenously expressing Bac5, how-
ever, TNF-α stimulation induced significantly higher amounts of MMP-9 protein. It is inter-
esting that Bac5 is able to both induce TNF-α transcription in one cell type, and enhance
sensitivity to it in another, and suggests it can potentially act as a signal mediator in support of
cytokine function. In constructing stable cell lines expressing AMP, we demonstrate a proof of
principle that these peptides can be produced more efficiently than existing synthetic methods
such as those using solid-phase chemistry [63], or using bacterial or yeast systems that are
complicated by auto-toxicity issues.
In vivo activity of Bac5
We identified macrophage recruitment in vivo in the presence of Bac5 that was sustained for
24 hours, independent of M. marinum infection. However, when bacteria and peptide were
co-injected, Bac5 promoted no additional macrophage recruitment above the level induced by
M. marinum alone. The ability of Bac5 to recruit macrophages independently may support an
early immune response when the peptide is located away from the immediate proximity of a
nascent infection. From a wider perspective, the ability of Bac5 to recruit macrophages high-
lights a potential application as a peptide-based vaccine adjuvant, considering that M. bovis
BCG vaccine has been shown to promote better protection against MTB challenge when acti-
vated macrophages are present [64].
We also observed a chemotactic effect of Bac5 on neutrophils at six hpi in synergy with M.
marinum, although the effect was not sustained over longer time periods. The lack of signifi-
cant cxcl-c1c transcriptional activity in vivo suggested that Bac5 did not recruit neutrophils via
induction of this chemokine.
Treatment with Bac5 resulted in significantly reduced bacterial burden at 72 hpi, potentially
due to the observed early enhanced recruitment of macrophages and neutrophils. While
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neutrophils reportedly lack the ability to efficiently phagocytose and kill free mycobacteria
[65], there is evidence that they can support killing by macrophages, as well as engulf and
destroy mycobacteria-infected macrophages [66].
Still, we only observed a reduced rate of bacterial infection, not control of or killing of
mycobacteria, and we suggest this may be due to an overall lack of pro-inflammatory cytokine
induction in the in vivo model, exacerbated by a lack of adaptive immunity. This is likely to
significantly affect the ability of the host to resist infection, and may limit the contribution of
Bac5.
While TNF-α produced by TLR-stimulated macrophages can activate macrophages, it opti-
mally requires co-stimulation with IFN-γ [67, 68], of which T-cells are a major source. CD4+
Th1 T-cell-produced IFN-γ and TNF-α can activate bystander resting macrophages and pre-
vent their infection by MTB [44, 69]. Non-activated macrophages, by contrast, are permissive
to mycobacterial infection [70, 71]. Clay et al have shown that macrophages are sufficient to
control bacillary burden of M. marinum in the embryonic zebrafish model without the contri-
bution of adaptive immunity [72]; however in that study, a high level of tnfa was found, sug-
gesting the macrophages were activated. There are conflicting reports of the ability of M.
marinum to induce tnf in zebrafish embryos. Some have described it to be a potent inducer of
tnfa [72, 73], whereas others have reported only weak or delayed induction [74, 75]. In our
hands, M. marinum was able to upregulate il-1β, but it was only detected in significant
amounts after 96 hours. Bac5, a potent inducer of il-1β in vitro, failed to upregulate it in vivo. A
possible explanation for the lack of either tnfa, il-1β or mmp-9 transcriptional activity observed
in vivo may be the presence of TGF-β in the developing embryo [76], which has been described
to inhibit IL-1β, TNF-α [77] and MMP-9 production [78].
Conclusions
AMP are a key component of the innate immune system, we therefore sought to study the
function of Bac5 purely in this context, modelling early infection of a host with a natural path-
ogen. We furthermore utilised in vitro systems to study the effects of Bac5 in a reductionist
approach. By definition, these models do not fully replicate the role of Bac5 in the bovine sys-
tem. Determining the physiological concentration of AMPs is notoriously difficult, but some
data is available. For context, the concentration of LL37 stored in human neutrophils and
found in plasma and adult airway fluid is in the range of 0.6–2 μg mL-1[79]. In our present
work, we injected 10 ng Bac5 per embryo; the chemotactic effects we observed therefore repre-
sent a potent function of Bac5. Additionally, in a physiological setting, the peptide itself would
be continually replenished by neutrophil degranulation, whereas our design represents a single
‘pulse-chase’ kinetic. Since the in vivo half-life of some AMPs can be just a few minutes [3], it
would be interesting to examine the impact of Bac5 when constitutively expressed in vivo
rather than using exogenous synthetic peptide.
In conclusion, we have demonstrated direct bactericidal activity of the proline-rich bovine
innate immune peptide, Bac5. For the first time, we show that Bac5 is able to variably kill some
mycobacterial species, and it supports macrophage activation in vitro in synergy with M. mari-
num. We also show that it is able to induce recruitment of macrophages, and that it can
enhance recruitment of neutrophils in the presence of M. marinum. A single dose of the pep-
tide was able to slow but not prevent infection of zebrafish embryos with M. marinum; a lack
of inflammatory cytokine induction in vivo may limit the potency of Bac5, particularly in the
absence of adaptive immunity. These findings point to Bac5 being a potentiator of the innate
immune response in response to infection beyond its recognised ability to kill Gram-negative
bacteria.
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Materials and methods
Stable expression of Bac5 in A549 human epithelial cells
To create stable A549 human epithelial cell lines expressing the active form of Bac5, we began
by synthesising the double-stranded DNA encoding Bac5 using overlap extension PCR with
primers for the entire coding sequence with Kozak sequence inserted at the 5’ end and using an
A-tailing polymerase. The sequence was directly cloned into pcDNA 3.3 (Invitrogen, UK) and
used to transform TOP10 E. coli and screened by ampicillin resistance and colony PCR. Positive
clones were confirmed by sequencing of plasmid minipreps (Qiagen Spin Miniprep). Since the
expression of the antimicrobial peptide is under the control of a CMV promoter, it is not
expressed during E. coli replication and so there is no auto-toxicity. Purified pcDNA3.3_Bac5
plasmid were linearised and introduced into human A549 cell lines (ATCC-LGC) using Lipo-
fectamineTM (Thermo Fisher Scientific) transfection reagent, and after 24 hours culture at
37 oC with 5% CO2 in DMEM Glutamax (Gibco) with 10% foetal calf serum, 100 μg ml-1 genta-
mycin (Sigma Aldrich) was added to the cell culture to select for chromosomally integration
and expression of the vector. Expression of Bac5 was confirmed by RNA extraction from the
cell lines followed by cDNA synthesis and PCR using Bac5-specific primers.
Synthetic peptides
All synthetic peptides were manufactured by Biomatik. All AMPs were resuspended in nucle-
ase-free water to a stock concentration of 10 mg/ml. Sequences were as follows: Bac5 = RFRPP
IRRPPIRPPFYPPFRPPIRPPIFPPIRPPFRPPLGPF; Epinecidin = GFIFHIIKGLFHAGKMIH
GLV; LL37 (Cathelicidin) = LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES.
Bacterial strains and maintenance
E. coli (strain HB101) was maintained at 37˚C in Luria-Bertani (LB) media or on LB agar
plates. M. marinum (strain M, ATCC BAA-535) was maintained at 28.5˚C in Middlebrook
7H9 media (BD), or on Middlebrook 7H11 or 7H10 plates (BD) supplemented with 10% Mid-
dlebrook Oleic Acid Albumin Dextrose Complex (OADC) media (BD and Stratech). All liquid
cultures were incubated with shaking at 150 rotations per minute (rpm) and liquid cultures of
M. marinum also contained 0.05% Tween-80. Where appropriate, growth media were supple-
mented with 25 μg/ml kanamycin and/or 50 μg/ml hygromycin. Where stated, M. marinum
(strain M, ATCC BAA-535) containing pMSP12:DsRed2[80] or pGFPHyg2[81] was used and
maintained as above.
In vitro activity of endogenous-expressed Bac5
To assess the activity of endogenously produced Bac5 peptide, cell culture supernatant was col-
lected from either A549 cells or Bac5_A549 cells. Alternatively, adherent cells were washed
three times with sterile PBS before harvesting using Accutase (Thermo Fisher Scientific) and
mechanical lysis using a sterile douncer. Protein concentration was normalised using modified
Bradford Assay, and equivalent amounts of either cell lysate or cell culture supernatant added
1:1 with lysogeny broth containing 1 x 105 CFU bacteria, either M. smegmatis, M. bovis BCG,
Burkholderia. thailandensis, Yersinia pseudotuberculosis IP32953 or E. coli. 96-well plates were
incubated at 37˚C for 24 hours before the addition of Alamar Blue reagent (Thermo Fisher Sci-
entific) for 1 hour and measurement of optical density at 590 and 620 nm. Metabolic activity
was calculated and normalised against the bacteria-free control.
To assess the effect of constitutive Bac5 expression on the responsiveness of the A549 cells
to mycobacterial PAMP or cytokine stimulation, we incubated 1x 105 cells in a 96 well plate
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with different MOI of either M. smegmatis, M. bovis BCG, or TNF-α. After 24 hours incuba-
tion at 37 oC, cell culture supernatant was harvested and centrifuged to pellet extracellular bac-
teria. Supernatant used measured for metalloprotease (MMP-9) and CXCL8 content by
enzyme-linked immunosorbent assay (ELISA) according to manufacturer’s instructions (both
Thermo Fisher Scientific).
In vitro activity of synthetic AMPs assay
M. marinum starter cultures were used at OD600 1.0 and E. coli starter cultures at OD600 0.5
(ensuring the bacteria were in logarithmic phase) before dilution in a solution of 1:4 (v:v) RPMI:
water to a concentration of 1.5x106 CFU per ml. 100 μl of bacterial solution (1.5x105 CFU /well)
was added to each well with 10 μl of appropriate 10X working AMP stock (prepared fresh in 1:4
(v:v, RPMI:water) and the 96-well plate incubated for 24 hours at 28.5 oC. For M. marinum exper-
iments, serial dilutions in 1X PBS were plated on 7H10 agar for each well and CFU counts taken
after 5 days of incubation at 28.5 oC. For E. coli experiments, serial dilutions in 1X PBS were plated
on LB agar for each well and CFU counts taken after overnight incubation at 28.5 oC. Three bio-
logical replicates per experiment were performed for each AMP concentration.
THP-1 cells maintenance
The THP-1 acute monocytic leukaemia cell line (ATCC TIB-202) was maintained in RPMI
1640 Medium, GlutaMAX supplement (Gibco) containing 10% FBS (heat-inactivated, Sigma-
Aldrich), 50 units/ml penicillin and 50 μg/ml streptomycin (penicillin/streptomycin, Sigma-
Aldrich). Cells were maintained at a density of 2x105 - 1x106 cells at 37˚C 5% CO2 in a humidi-
fied chamber. All procedures were carried out using cells between passages 9 and 12.
THP-1 cell assays with AMPs
THP-1 cells were plated at 5x105 cells/well to 96-well plates in RPMI 1640 Medium, Gluta-
MAX supplement containing 10% FBS, 50 units/ml penicillin and 50 μg/ml streptomycin. Fol-
lowing plating, cells were incubated for 24 hours at 37˚C 5% CO2 with or without activation
with 20 ng/ml PMA (phorbol 12-myristate 13-acetate, Sigma-Aldrich) as stated in figure leg-
ends. Cell media was changed to RPMI 1640 Medium, GlutaMAX supplement containing 10%
FBS only, and all cells incubated for a further 24 hours without PMA or antibiotics. Mean-
while, M. marinum was cultured to an OD600 of 1.0, bacteria harvested by centrifugation, and
bacteria resuspended in RPMI 1640 Medium, GlutaMAX supplement containing 10% FBS
only. Following 24 hours rest without PMA, 10 μl of bacterial suspension or 10 μl media only
was added to each well. Infection with M. marinum at MOI 1:1 was allowed to proceed for 3
hours at 33˚C 5% CO2, cells were washed 3x with RPMI 1640 Medium, GlutaMAX supple-
ment (no additives), and cell media was replaced with RPMI 1640 Medium, GlutaMAX sup-
plement (no additives) containing no AMP or 15 ng/μl of the AMP indicated. Cells were then
incubated for the stated times at 33˚C 5% CO2.
qRT-PCR sampling was performed by adding 100 μl lysis buffer (MagMAX-96 Total RNA
Isolation Kit) per sample, and proceeding with sample processing according to the manufac-
turer’s recommendations. Pools of two wells were used for each sample by transferring the
100 μl lysis buffer from the first well to the second before processing the sample.
Zebrafish lines and maintenance
Zebrafish lines used in this study were Tg(mpeg-1:mCherry)gl23[82], casper Tg(mpx:GFP)i114
[83–85] and casper Tg(Lyz:GFP)nz117[86]. All zebrafish embryos in this study were under
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6dpf and larvae were maintained at 28.5˚C in 0.5X E2[87], including infected zebrafish. Wild-
type zebrafish were purchased from the Zebrafish International Resource Center (Eugene,
OR). Survival was monitored daily and dead zebrafish embryos and larvae removed. Where
required for injection or imaging procedures, zebrafish embryos and larvae were anaesthetised
in E2 containing 4.2% MS-222 (3-aminobenzoic acid ethyl ester, Sigma-Aldrich), followed by
recovery in 0.5X E2 media containing no anaesthetic. Where euthanasia was performed, zebra-
fish embryos and larvae were terminally anaesthetised in 0.5X E2 containing 15% MS-222 and
death verified after overnight incubation. To prevent melanisation and aid imaging, Tg(mpeg-
1:mCherry) zebrafish were maintained from 24hpf in 0.5X E2 containing 30 mg/L PTU (1-phe-
nyl-2-thiourea, Sigma-Aldrich).
Zebrafish injections
Embryos were dechorionated manually prior to injections using fine forceps. Hindbrain ven-
tricle (HBV) injections were performed at 2 days post-fertilisation (dpf, 50–54 hpf) with an IM
300 microinjector with injection volumes of approximately 1 nl. Embryos were injected with
one of four possible injection solutions during this study, as specified in figure legends: 1X PBS
(mock); 1X PBS containing M. marinum; 10 mg/ml BAC; or 10 mg/ml BAC containing M.
marinum. The solution of 1X PBS was chosen as an osmotically-balanced non-inflammatory
control (mock) injection. All injection solutions contained phenol red dye (Sigma-Aldrich) at
a final concentration of 0.0005%.
For zebrafish injections, M. marinum expressing DsRed2[80] or GFPmut3[81] was grown
to mid-logarithmic phase (OD600 1.0). Growth curves were initially performed for each strain
to determine the appropriate dilutions; bacterial cultures were concentrated 5-fold for injec-
tions. Cells were harvested by centrifugation, washed 3X in 1X PBS, and resuspended at the
appropriate dilution for injections in 1X PBS for M. marinum only injections. Co-injection
solutions were first resuspended at the appropriate dilution in 100 μl 1X PBS to provide the
Mock/M. marinum injection solution, with 10 μl of this preparation then being harvested by
centrifugation and resuspended in 10 μl of 10 mg/ml Bac5 to provide the Bac5/M. marinum
injection solution. Injection doses were verified by injecting bacterial solutions directly into a
10 μl drop of sterile 1X PBS and plating the drop to 7H10 for CFU counting after 5 days of
incubation. Three 1X PBS drop injections were plated for each experiment.
Zebrafish were sampled for qRT-PCR following injections by euthanizing the zebrafish,
homogenising the samples using a pestle (Kimble-Chase) in 100 μl lysis buffer (MagMAX-96
Total RNA Isolation Kit), and proceeding with sample processing using the kit according to
manufacturer’s recommendations. qRT-PCR was performed for pools of 3 whole zebrafish
embryos per sample at 6 hpi and 24 hpi, or individual zebrafish larvae samples at 96 hpi.
Zebrafish microscopy and image quantification
Live zebrafish embryos and larvae were imaged using a Leica M205 FA fluorescence stereomi-
croscope. To enable quantification of infection progression parameters from images of zebra-
fish, transgenic zebrafish lines expressing fluorescently labelled immune cells and
fluorescently-labelled M. marinum strains were used. Z-stack images of the zebrafish HBV
region were acquired in the dorsal view with the z-stack range capturing the entire head region
from the dorsal to ventral sides. All images were acquired for infected and uninfected zebrafish
using standardised settings for each infection parameter to be quantified such that repeat
experiments could be compared and/or data pooled. All zebrafish were manually positioned in
the dorsal orientation to ensure the accuracy of parameter quantification from images. Data
for zebrafish which died or suffered from pericardial and/or yolk sac oedema during the course
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of experiments was excluded from the analyses presented for all time points. All quantifica-
tions and brightness and contrast adjustments for images presented in this study were per-
formed in Icy (open-source image analysis software, http://icy.bioimageanalysis.org/).
To permit the quantification of HBV region leukocyte recruitment and bacterial burden
following injections, images were first processed. The in-focus z-slice was extracted from z-
stacks for analysis. The selected z-slice was defined as the depth of slice from the top of the
head in which bacterial fluorescence was seen in the majority of infected zebrafish groups;
slices at that depth were then extracted and processed for all zebrafish in the experiment. To
rapidly and reproducibly define a standardised HBV region for analysis, selected z-slice images
were cropped at the otic vesicle, such that quantification was performed for the zebrafish head
region from the tip to the otic vesicle—referred to as the “HBV region” throughout this study.
Cropping facilitates the removal of the yolk sac and lymph nodes from the regions to be pro-
cessed, eliminating issues with autofluorescence and large collections of immune cells in
images, respectively.
The processed z-slice was analysed using both an Icy FPC protocol to determine the bacte-
rial burden, and the Icy Spot Detector plugin to determine leukocyte recruitment to the HBV
region. The FPC protocol is based upon the Icy Thresholded Pixel Density plugin (developed
by Fabrice de Chaumont, with the FPC protocol provided as “Pixel Density (batch mode) pro-
tocol” on the Icy website) and integrates the number of pixels in each image of infected zebra-
fish with values above a background threshold, as determined by matched images of
uninfected animals. The background threshold intensity is defined as the value for the highest
intensity pixel in the uninfected control images. The Icy Spot Detector plugin [88] detects the
number of pixel clusters of user-defined scale and sensitivity within an image, and was used to
detect the number of fluorescently-labelled cells present in an image. In addition to quantifica-
tion using the Spot Detector plugin, the Icy FPC protocol was also used to quantify neutrophil
recruitment to the HBV region in co-injection experiments (Fig 4). This was due to imperfect
resolution of neutrophil cell clusters at the 72 hpi time point by the Icy Spot Detector plugin;
caused by the use of standardised image acquisition settings throughout these experiments
from 6 to 72 hpi to permit comparison of the results at different time points.
To enable the separation of zebrafish into equal groups of infection burden and distribution
for sequential injection experiments, single images of the HBV region were acquired in the
dorsal view with the infecting bacteria in-focus at 24 hpi. These images were cropped at the
otic vesicle as described above to provide the HBV region for analysis. The processed images
were analysed using the Icy FPC protocol as above to determine the bacterial burden, zebrafish
were separated into four groups of equal infection burden and any surplus infected zebrafish
were discarded at this point. The four groups of zebrafish were then treated with sequential
injections of Mock or Bac5 as described in figure legends.
qRT-PCR
Following RNA extraction from samples using the MagMAX-96 Total RNA Isolation Kit
(Ambion), RNA quantity and quality was determined using a NanoDrop 1000 (Thermo Scien-
tific). The High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used
according to manufacturer’s recommendations with 125 ng of total RNA sample per reaction.
qRT-PCR was performed with 2% of the generated cDNA per reaction using the Taqman Fast
Universal PCR Master mix, no AmpErase UNG (Applied Biosystems) and Taqman primer
and probes assays (Applied Biosystems). All reactions were performed in duplicate using a
7500 Fast Real-Time PCR System (Applied Biosystems). Obtained cycle thresholds were nor-
malised to 18S and expressed relative to one control sample for each experiment. Taqman
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primer and probes assays used were: 18S rRNA (4319413E), il-1β (Dr03114368_m1), mmp-9
(Dr03139882_m1), TNF-α (Dr03126850_m1), cxcl-c1c (Dr03436643_m1), and ifn-phi1
(Dr03100938_m1).
Statistical analysis
All statistical analyses were carried out using GraphPad Prism 4.0 software (GraphPad Soft-
ware, La Jolla California USA, www.graphpad.com). The D’Agostino-Pearson omnibus test
was used to confirm a normal distribution of data (parametric data). To compare two groups,
unpaired two-tailed T-tests or Mann-Whitney tests were used for parametric or non-paramet-
ric datasets, respectively. To compare more than two groups, one-way ANOVA followed by
Bonferroni’s multiple comparison test or Kruskal-Wallis test followed by Dunn’s multiple
comparison test were used for parametric or non-parametric data, respectively. P values of less
than 0.05 were deemed statistically significant with ��� p<0.001, �� p<0.01 and � p<0.05.
Supporting information
S1 Fig. Single injection of Bac5 to the HBV does not affect il-1β, mmp-9, tnfa or cxcl-c1c
transcription in uninfected or M. marinum-infected zebrafish. Two dpf Tg(mpeg-1:
mCherry) zebrafish embryos were injected with Mock, 10 ng Bac5, Mock/M. marinum
(Mmar) (approx. 190 CFU) or Bac5/Mmar. Fold changes of il-1β, mmp-9, cxcl-c1c and tnfa
mRNA levels were assessed by qRT-PCR, normalised to 18S and expressed relative to one con-
trol uninjected sample. Samples were taken at 6 hpi (A), 24 hpi (B) and 96 hpi (C). Each data
point in (A-B) represents a pool of three fish (n = 33 for uninjected and Bac5/Mmar injected
groups at 24 hpi, and n = 36 for all other groups at 6 hpi and 24 hpi), each data point in (C)
represents an individual fish (n = 15). Data were pooled from three independent experiments.
Error bars represent S.E.M. Mann-Whitney test for 96 hpi tnfa data and Kruskal-Wallis with
Dunn’s post-test for all other data. ���p<0.001. Statistical significance between M. marinum-
infected and uninfected groups is displayed relative to the Mock control group only for clarity.
The uninjected control group is shown for reference only; statistical significance to this group
is not shown for clarity.
(TIF)
S2 Fig. Delayed injection of Bac5 to the HBV of M. marinum-infected zebrafish at 72hpi or
90hpi does not affect cytokine transcription. Two days post-fertilisation Tg(mpeg-1:
mCherry) zebrafish embryos were injected into their HBV with approximately 180 CFU M.
marinum expressing GFP. Zebrafish embryos were live-imaged using a fluorescence stereomi-
croscope at 24 hpi, individual bacterial burdens calculated using the Icy FPC protocol, and
embryos were separated into four groups of equal infection burden and distribution. Zebrafish
were then injected with either Mock or 10 ng BAC at 72 hpi or 90 hpi. Fold changes of il-1β,
mmp-9, tnfa and cxcl-c1c mRNA levels were assessed at 96 hpi by qRT-PCR, normalised to 18S
and expressed relative to one control sample. Data pooled from two independent experiments
is shown (n = 19 for 90 hpi Mock injection group and n = 20 for all other groups). Each data
point represents an individual fish. Error bars represent S.E.M. Kruskal-Wallis with Dunn’s
post-test. �p<0.05, ��p,0.01.
(TIF)
S3 Fig. Endogenously expressed Bac5 confers antibacterial activity and enhances cytokine
and chemokine response to infection. A549 cells and A549 cell lines stably expressing Bac5
were tested for ability to restrict bacterial metabolic activity. Cell lysate (A) or culture superna-
tant (B) were incubated neat with different species of bacteria (MOI of 1) and metabolic
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activity was assessed after 24 h by Alamar Blue assay. To asses chemokine and cytokine
responses, cell lines were seeded at 1 x 105 in 96-well plate and challenged with different MOI
of bacteria, or 10–100 ng/ml TNFα over 24 hrs. Cell culture supernatant was used to perform
either MMP-9 (C) or CXCL8 (D) ELISA and normalised against the untreated negative con-
trol. � p<0.01 Student’s T-test.
(TIF)
S4 Fig. Delayed injection of Bac5 does not affect neutrophil recruitment in infected
embryos. Two days post-fertilisation casper Tg(LysC:GFP) zebrafish embryo groups were
injected into their HBV with approximately 220 CFU M. marinum expressing DsRed2. Zebra-
fish embryos were live-imaged using a fluorescence stereomicroscope at 24 hpi, individual bac-
terial burdens calculated using the Icy FPC protocol, and embryos were separated into four
groups of equal infection burden and distribution. Two groups were treated with Mock or 10
ng Bac5 at 48 hpi and two groups were treated with repeated doses of Mock or 10 ng Bac5 at
48 hpi and 96 hpi. Zebrafish embryos were live-imaged using a fluorescence stereomicroscope
and z-stack images of the HBV region acquired at 72 hpi and 120 hpi. (A-F) Representative
fluorescence images of fish from the same single experiment are shown at 72 hpi (A-B) and
120 hpi (C-F). Images of the neutrophil and bacterial fluorescence channels are shown sepa-
rated by white dashed line. Scale bar 100 μm. (G-H) Neutrophils in the HBV region were
quantified from fluorescence images of zebrafish embryos using Icy Spot Detector plugin at 72
hpi (G) and 120 hpi (H). Sample size (n): 111, 109 (G) and 47, 43, 45, 41 (H). Data pooled
from three independent experiments is shown. Error bars represent S.E.M. Unpaired t-test
(G), one-way ANOVA with Bonferroni’s post-test (H) showed no significant differences.
(TIF)
S5 Fig. Delayed injection of Bac5 does not affect bacterial burden or survival of infected
embryos. Two days post-fertilisation casper Tg(LysC:GFP) zebrafish embryos were injected
into their HBV with approximately 220 CFU M. marinum expressing DsRed2. Zebrafish
embryos were live-imaged using a fluorescence stereomicroscope at 24 hpi, individual bacte-
rial burdens calculated using the Icy FPC protocol, and embryos were separated into four
groups of equal infection burden and distribution. Two groups were treated with mock or 10
ng Bac5 at 48 hpi and two groups were treated with repeated doses of mock or 10 ng Bac5 at
48 hpi and 96 hpi. Zebrafish embryos were live-imaged using a fluorescence stereomicroscope
and z-stack images of the HBV region acquired at 72 hpi and 120 hpi (A). Survival of all zebra-
fish embryo treatment groups was recorded, including dosed with single injection of Bac5 at
48 hpi and with second injection at 96 hpi (B). Data pooled from three independent experi-
ments is shown. Error bars represent S.E.M. Sample size, 111 and 109 (72 hpi) and 47, 43, 45,
41 (120 hpi). Kruskal-Wallis with Dunn’s post-test (A) and survival analysis (B) showed no
significant differences.
(TIF)
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